WallStreetZenWallStreetZen

NASDAQ: ATTO
Attovia Therapeutics Inc Stock Ownership - Who owns Attovia Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Attovia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Frazier Life Sciences XI LP10% Owner2026-08-06588,235$17.00
$10.00MBuy
Redmile Group LLC10% Owner2026-08-06200,000$17.00
$3.40MBuy
Redmile Group LLC10% Owner2026-08-06400,000$17.00
$6.80MBuy
Sanofi10% Owner2026-08-06300,000$17.00
$5.10MBuy
Venbio Global Strategic Fund IV LP10% Owner2026-08-06382,352$17.00
$6.50MBuy

1 of 1

ATTO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATTO insiders and whales buy or sell their stock.

ATTO Shareholders

What type of owners hold Attovia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences XI LP14.30%6,154,213$122.10MInsider
Venbio Global Strategic Fund IV LP9.72%4,181,367$82.96MInsider
Alamar Holdco LLC7.50%3,229,278$64.07MInsider
Redmile Group LLC5.03%2,165,708$42.97MInsider
Deep Track Biotechnology Master Fund Ltd4.55%1,957,138$38.83MInsider
Sanofi2.52%1,082,855$21.48MInsider
Attovia Therapeutics Inc0.77%333,268$6.61MInsider
Petter Veiby0.24%104,951$2.08MInsider
Zaneta Odrowaz0.24%103,269$2.05MInsider
Angie You0.12%52,852$1.05MInsider

1 of 2

ATTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABVC3.14%80.87%
ABVX63.37%0.00%
ACET28.27%71.73%Net Buying
ACXP4.23%59.85%
AARD46.75%46.87%Net Buying
View Top Biotech Stocks

Attovia Therapeutics Stock Ownership FAQ

Who owns Attovia Therapeutics?

Attovia Therapeutics (NASDAQ: ATTO) is owned by 0.00% institutional shareholders, 45.01% Attovia Therapeutics insiders, and 54.99% retail investors. Frazier Life Sciences XI LP is the largest individual Attovia Therapeutics shareholder, owning 6.15M shares representing 14.30% of the company. Frazier Life Sciences XI LP's Attovia Therapeutics shares are currently valued at $114.78M.

If you're new to stock investing, here's how to buy Attovia Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.